ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Macrophage Derived TGF-β Recruits BMSCs for Initiation of Bone Formation During Fracture Healing.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Impaired fracture healing remains a major clinical challenge, with approximately 10% of fractures progressing to nonunion or delayed union. Although numerous studies have focused on strategies to promote fracture healing, the mechanisms governing the initiation phase of repair remain poorly understood. This study aimed to investigate the contribution of macrophage-derived TGF-β1 to the initiation of early fracture repair. A murine femoral osteotomy model was used to study fracture healing. We examined the temporal relationship among bone healing, callus maturation, pSmad2/3 positive cells, and osteoprogenitors. TGF-β1 signaling was systemically inhibited using a neutralizing antibody. Macrophages were selectively depleted in LysM-iDTR mice by diphtheria toxin administration. The source and expression levels of TGF-β1 at the fracture site were determined by pSmad2/3 staining and RT-qPCR. Fracture healing was assessed using micro-CT, histomorphometry, and immunohistochemistry. TGF-β1 signaling peaked during the inflammatory phase and preceded osteoprogenitor recruitment. Systemic inhibition of TGF-β1 or selective macrophage depletion before fracture establishment severely disrupted mesenchymal stem cell (MSC) recruitment and bone formation. In contrast, late-stage macrophage depletion did not substantially affect bone healing. CD86+ macrophages were identified as a key early source of TGF-β1. Importantly, local delivery of TGF-β1 via hydrogel microspheres during the early stage rescued osteogenic repair in macrophage-deficient mice. CD86+ macrophage-derived TGF-β1 is essential for initiating fracture repair by recruiting MSCs and promoting osteogenesis. Targeting this pathway may represent a novel therapeutic strategy to enhance bone regeneration in cases of impaired healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.